Jianmin Chen

Charterhouse Square
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Correction to: IkB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD.

Correction to: IkB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD.

Journal: Journal of the American Society of Nephrology : JASN

Published: June 15, 2026

Interleukin-6 blockade modulates monocyte recruitment to protect against diastolic dysfunction associated with inflammatory arthritis.

Interleukin-6 blockade modulates monocyte recruitment to protect against diastolic dysfunction associated with inflammatory arthritis.

Journal: Arthritis research & therapy

Published: July 04, 2025

Correction: RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearance.

Correction: RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearance.

Journal: Frontiers in immunology

Published: July 03, 2025

Retraction Note: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.

Retraction Note: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.

Journal: Diabetologia

Published: April 29, 2025

Immunomodulation by AZD1656 reverses cardiac dysfunction, metabolic remodelling and reduces infarct size in type 2 diabetic cardiomyopathy.

Immunomodulation by AZD1656 reverses cardiac dysfunction, metabolic remodelling and reduces infarct size in type 2 diabetic cardiomyopathy.

Journal: bioRxiv : the preprint server for biology

Published: April 28, 2025

Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis.

Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis.

Journal: EMBO molecular medicine

Published: August 01, 2024

Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation.

Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation.

Journal: Pharmacology & therapeutics

Published: May 13, 2024

Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2 diabetic cardiomyopathy.

Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2 diabetic cardiomyopathy.

Journal: Nature cardiovascular research

Published: April 23, 2024

Editorial: Cardiometabolic diseases and inflammatory responses.

Editorial: Cardiometabolic diseases and inflammatory responses.

Journal: Frontiers in immunology

Published: February 08, 2024

The Annexin-A1 mimetic RTP-026 promotes acute cardioprotection through modulation of immune cell activation.

The Annexin-A1 mimetic RTP-026 promotes acute cardioprotection through modulation of immune cell activation.

Journal: Pharmacological research

Published: August 08, 2023

Formyl Peptide Receptor Type 2 Deficiency in Myeloid Cells Amplifies Sepsis-Induced Cardiac Dysfunction.

Formyl Peptide Receptor Type 2 Deficiency in Myeloid Cells Amplifies Sepsis-Induced Cardiac Dysfunction.

Journal: Journal of innate immunity

Published: December 02, 2022

Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease.

Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease.

Journal: eLife

Published: September 14, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026